Ethos Technologies Inc. (LIFE) — Valuation Snapshot
Updated Nov 10, 2026 · bank / insurer · relative-multiples view · descriptive, not a DCF, not advice
Ethos Technologies Inc. (LIFE) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing, so there is no meaningful 'free cash flow' to discount. Instead of a misleading intrinsic-value number, this page reads LIFE the way financials are actually valued — on relative multiples such as price-to-earnings and, above all, price-to-book — plus a plain description of where the stock trades. It is a descriptive snapshot, not a valuation, and not investment advice.
On the numbers we do have, LIFE trades at a recent price of $35.77, a market capitalisation of about $2,325,593,856, sitting 65% of the way up its 52-week range ($9.45–$49.98), on the NasdaqGS.
The standard alternative to a DCF is relative valuation — comparing LIFE's trading multiples against a sector benchmark. Here that gives Fwd P/E of 14.7× (in line with the peer median of 13.4×); P/S of 3.2× (cheaper than the peer median of 4.8×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
Finally, a price-based read — explicitly not a valuation. LIFE is in a mixed trend, trading -28.4% from its 52-week high. Over the past year the stock is +98.9%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
To be exact about what this page is not: we are not saying the numbers for LIFE are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.
Relative valuation — LIFE vs peers
| Multiple | LIFE | Peer median | |
|---|---|---|---|
| Fwd P/E | 14.7× | 13.4× | in line with |
| P/S | 3.2× | 4.8× | cheaper than |
Sector benchmark (bellwethers, not direct competitors).
Asset / book-value view
We are not showing a price-to-book for this listing: the book value we have does not belong to the same share class as the price, so any ratio of the two would be arithmetic rather than a valuation.
Price-based snapshot
Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.
Explore more
Most undervalued stocks (per our valuation) · All valued stocks · Interactive LIFE viewA descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.